The introduction of OMB Circular A-133 states under 4. Policy that "This
Circular does not apply to non-U.S. based entities expending Federal awards
received either directly as a recipient or indirectly as a subrecipient."

>X-UIDL: 832607650.002
>Date:         Sun, 19 May 1996 14:53:00 +0200
>Reply-To: Research Administration Discussion Group
>              <xxxxxx@health.state.ny.us>
>Sender: Research Administration Discussion Group
>              <xxxxxx@health.state.ny.us>
>From: Research Administration Discussion Group
>              <xxxxxx@health.state.ny.us>
>X-From:       Elinor Slater <xxxxxx@VMS.HUJI.AC.IL>
>Subject:      Re: A-21 revised and recompiled
>X-To:         xxxxxx@albnydh2.health.state.ny.us
>To: Multiple recipients of list RESADM-L <xxxxxx@health.state.ny.us>
>
>Has anyone heard that the new A-21 has eliminated A-133 audits for overseas
>institutions? If so, where can we find it in writing?
>
>
>Elinor Slater
>Coordinator, US-Sponsored Research Programs
>Authority for Research and Development
>Hebrew University of Jerusalem
>Jerusalem 91904
>
>tel: 972-2-6586638
>fax: 972-2-664740
>Email: xxxxxx@vms.huji.ac.il
>
>